Compounds > fluoromisonidazole
Page last updated: 2024-08-26

fluoromisonidazole and Glioblastoma

fluoromisonidazole has been researched along with Glioblastoma in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.35)18.2507
2000's4 (17.39)29.6817
2010's13 (56.52)24.3611
2020's5 (21.74)2.80

Authors

AuthorsStudies
Qin, J; Tang, Y; Wang, B1
Akasaki, Y; Fukasawa, N; Miyake, K; Murayama, Y; Ogawa, D; Shimoda, M; Suzuki, K; Suzuki, T; Takei, J; Tanaka, T; Yamamoto, Y1
Abdo, RA; Bentourkia, M; Fernandez, P; Lamare, F1
Furuya, S; Hirata, K; Kobayashi, H; Kobayashi, K; Kudo, K; Kuge, Y; Magota, K; Manabe, O; Shiga, T; Tamaki, N; Terasaka, S; Toyonaga, T; Yamaguchi, S1
Brenner, AJ; Clarke, GD; Floyd, JR; Fox, PT; Huang, S; Hyun, H; Jerabek, PA; Lee, EQ; Michalek, JE; Muzi, M; Reardon, DA; Schmainda, KM; Wen, PY1
Bernaudin, M; Berro, DH; Chakhoyan, A; Collet, S; Constans, JM; Derlon, JM; Guillamo, JS; Guillouet, S; Hatt, M; Lechapt-Zalcman, E; Perrio, C; Valable, S; Visvikis, D1
Barré, L; Bernaudin, M; Chakhoyan, A; Collet, S; Constans, JM; Delcroix, N; Guillamo, JS; Kauffmann, F; Lechapt-Zalcman, E; MacKenzie, ET; Petit, E; Touzani, O; Valable, S1
Andronesi, OC; Barboriak, D; Ellingson, B; Fink, J; Gerstner, ER; Greco, E; Hanna, L; Kim, D; Kostakoglu, L; Mankoff, D; Mintz, A; Muzi, M; Prah, M; Ratai, EM; Richards, T; Schmainda, K; Sorensen, G; Zhang, Z1
Hirata, K; Houkin, K; Kobayashi, H; Shiga, T; Terasaka, S; Yamaguchi, S1
Hamaji, M; Harada, H; Kimura, H; Koizumi, K; Koyasu, S; Nakamoto, Y; Nobashi, T; Sano, K; Togashi, K; Tsuji, Y1
Barboriak, DP; Eikman, EA; Ellingson, BM; Fink, JR; Gerstner, ER; Greco, E; Hanna, L; Kostakoglu, L; Mankoff, DA; Mintz, A; Muzi, M; Prah, M; Ratai, EM; Schmainda, KM; Sorensen, AG; Zhang, Z1
Anzellotti, AI; Frank, JE; Hillesheim, DA; Khachaturian, MH; Merrill, JR; Yuan, H1
Hattori, N; Hirata, K; Ito, YM; Kobayashi, H; Kobayashi, K; Kuge, Y; Manabe, O; Shiga, T; Tamaki, N; Tanaka, S; Terasaka, S; Toyonaga, T; Watanabe, S; Yamaguchi, S1
Adamsen, TC; Chakraborty, G; Harpold, HL; Krohn, KA; Muzi, M; Rockne, R; Spence, AM; Swanson, KR; Wang, CH1
Alvord, EC; Chakraborty, G; Hadley, J; Krohn, KA; Muzi, M; Rockne, R; Spence, AM; Swanson, KR; Szeto, MD1
Kawai, N; Kudomi, N; Maeda, Y; Miyake, K; Nishiyama, Y; Okada, M; Tamiya, T; Yamamoto, Y1
Alessio, AM; Alvord, EC; Anderson, AR; Chakraborty, G; Champley, K; Claridge, J; Gu, S; Kinahan, PE; Krohn, KA; Muzi, M; Rockne, R; Spence, AM; Swanson, KR1
De Clermont, H; Fernandez, P; Huchet, A; Lamare, F; Rivière, A1
Aoyama, H; Hirata, K; Houkin, K; Kobayashi, H; Murata, J; Narita, T; Onodera, S; Shiga, T; Tanaka, S; Terasaka, S1
Hattori, N; Hirata, K; Houkin, K; Kobayashi, H; Kuge, Y; Magota, K; Shiga, T; Tamaki, N; Tanaka, S; Terasaka, S; Yamaguchi, S1
Boerman, OC; Bussink, J; Kaanders, JH; Laverman, P; Lok, J; Oyen, WJ; Philippens, M; Troost, EG; van der Kogel, AJ1
Adamsen, TC; Krohn, KA; Link, JM; Muzi, M; O'Sullivan, F; Rajendran, JG; Rockhill, JK; Rostomily, RC; Silbergeld, DL; Spence, AM; Swanson, KR; Swanson, PE; Yagle, KJ1
Budinger, TF; Gilbert, JC; Mathis, CA; Prados, MD; Valk, PE1

Reviews

1 review(s) available for fluoromisonidazole and Glioblastoma

ArticleYear
Usefulness of FMISO-PET for glioma analysis.
    Neurologia medico-chirurgica, 2013, Volume: 53, Issue:11

    Topics: Adult; Animals; Brain Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Misonidazole; Oxygen; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results

2013

Trials

4 trial(s) available for fluoromisonidazole and Glioblastoma

ArticleYear
Analysis of hypoxia in human glioblastoma tumors with dynamic 18F-FMISO PET imaging.
    Australasian physical & engineering sciences in medicine, 2019, Volume: 42, Issue:4

    Topics: Brain Neoplasms; Carotid Artery, Common; Glioblastoma; Humans; Image Processing, Computer-Assisted; Misonidazole; Positron-Emission Tomography; Time Factors; Tumor Burden; Tumor Hypoxia

2019
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
    PloS one, 2018, Volume: 13, Issue:6

    Topics: Aged; Brain; Brain Neoplasms; Female; Glioblastoma; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Prognosis; Proton Magnetic Resonance Spectroscopy; Radiopharmaceuticals; ROC Curve; Tumor Hypoxia

2018
Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
    European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Cell Hypoxia; Female; Glioblastoma; Humans; Male; Methionine; Middle Aged; Misonidazole; Positron-Emission Tomography; Tumor Burden

2011
¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:5

    Topics: Adult; Aged; Anaplasia; Biological Transport; Brain Neoplasms; Diagnosis, Differential; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Misonidazole; Neoplasm Grading; Positron-Emission Tomography

2012

Other Studies

18 other study(ies) available for fluoromisonidazole and Glioblastoma

ArticleYear
Regional 18F-fluoromisonidazole PET images generated from multiple advanced MR images using neural networks in glioblastoma.
    Medicine, 2022, Jul-29, Volume: 101, Issue:30

    Topics: Bayes Theorem; Glioblastoma; Humans; Misonidazole; Neural Networks, Computer; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2022
    World neurosurgery, 2023, Volume: 175

    Topics: B7-H1 Antigen; Bevacizumab; Brain Neoplasms; Glioblastoma; Humans; Immunohistochemistry; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment

2023
Influence of the scan time point when assessing hypoxia in
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:8

    Topics: Glioblastoma; Humans; Hypoxia; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals

2020
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and
    Scientific reports, 2021, 04-07, Volume: 11, Issue:1

    Topics: Adult; Aged; Bevacizumab; Biomarkers, Pharmacological; Brain Neoplasms; Cerebral Blood Volume; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Positron-Emission Tomography; Progression-Free Survival; Tumor Hypoxia; Young Adult

2021
Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI,
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021, Volume: 62, Issue:10

    Topics: Adult; Glioblastoma; Humans; Middle Aged; Misonidazole; Positron-Emission Tomography

2021
FMISO-PET-derived brain oxygen tension maps: application to glioblastoma and less aggressive gliomas.
    Scientific reports, 2017, 08-31, Volume: 7, Issue:1

    Topics: Adult; Aged; Brain Mapping; Brain Neoplasms; Female; Glioblastoma; Gray Matter; Humans; Hypoxia, Brain; Male; Middle Aged; Misonidazole; Perfusion Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve; White Matter

2017
Evaluation of Tumor-associated Stroma and Its Relationship with Tumor Hypoxia Using Dynamic Contrast-enhanced CT and (18)F Misonidazole PET in Murine Tumor Models.
    Radiology, 2016, Volume: 278, Issue:3

    Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Female; Glioblastoma; Hypoxia; Immunohistochemistry; Mice; Misonidazole; Pancreatic Neoplasms; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiographic Image Interpretation, Computer-Assisted; Tomography, X-Ray Computed

2016
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Oct-15, Volume: 22, Issue:20

    Topics: Adult; Aged; Biomarkers; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neovascularization, Pathologic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tumor Hypoxia

2016
Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO).
    Current radiopharmaceuticals, 2016, Volume: 9, Issue:3

    Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Chromatography, High Pressure Liquid; Glioblastoma; Humans; Mice; Misonidazole; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tissue Distribution

2016
Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:4

    Topics: Adult; Aged; Blood Glucose; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioblastoma; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Oxygen; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2017
Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:1

    Topics: Adult; Aged; Female; Gadolinium; Glioblastoma; Humans; Hypoxia; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Survival Analysis; Tumor Burden

2009
Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas.
    Cancer research, 2009, May-15, Volume: 69, Issue:10

    Topics: Adult; Brain Neoplasms; Cell Division; Computer Simulation; Contrast Media; Female; Fluorine Radioisotopes; Gadolinium; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Neoplasm Invasiveness; Positron-Emission Tomography

2009
Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.
    Mathematical medicine and biology : a journal of the IMA, 2012, Volume: 29, Issue:1

    Topics: Adult; Brain Neoplasms; Cell Proliferation; Computer Simulation; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Male; Mathematical Concepts; Misonidazole; Models, Biological; Necrosis; Neoplasm Invasiveness; Neovascularization, Pathologic; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; User-Computer Interface

2012
Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:12

    Topics: Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Misonidazole; Positron-Emission Tomography

2011
Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: changes defined by 18F-fluoromisonidazole positron emission tomography: two case reports.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:2

    Topics: Aged; Antineoplastic Agents, Alkylating; Cell Hypoxia; Chemoradiotherapy, Adjuvant; Dacarbazine; Disease Progression; Dose Fractionation, Radiation; Female; Glioblastoma; Humans; Male; Middle Aged; Misonidazole; Oxygen; Positron-Emission Tomography; Radiation-Sensitizing Agents; Temozolomide; Treatment Outcome

2012
Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2006, Volume: 80, Issue:2

    Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Fluorine Radioisotopes; Glioblastoma; Head and Neck Neoplasms; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Misonidazole; Neoplasms; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Radionuclide Imaging

2006
Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, May-01, Volume: 14, Issue:9

    Topics: Adult; Aged; Brain Neoplasms; Cell Hypoxia; Disease Progression; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Regression Analysis

2008
Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:12

    Topics: Adult; Astrocytoma; Brain Neoplasms; Cell Hypoxia; Fluorine Radioisotopes; Glioblastoma; Humans; Male; Middle Aged; Misonidazole; Tomography, Emission-Computed

1992